Table of Contents
Among the products for hemophilia A and B that are likely to reach the market within the next 4 years are modified recombinant factor replacements that could reduce injection frequencies significantly, making once-a-week prophylaxis a reality.Assess key pipeline products with regards to current gold-standard therapies.Identify the prosp...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alexandra
+1 71 86 18 43 02
This report provides data on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Rheumatoid Arthritis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rheumatoid Arthritis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Company Profiles10 Companies
Reportlinker.com © Copyright 2013. All rights reserved.